Cytokinetics
CYTK
$59.53
Share price
-0.65%
Change (1 day)
57.45%
Change (1 year)
Categories
Market capitalization of Cytokinetics (CYTK)
Market cap: $6.24 Billion
As of May 2024 Cytokinetics has a market cap of $6.24 Billion. This makes Cytokinetics the world's 2334th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cytokinetics from 2004 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $6.24 B | -23.75% |
| 2023 | $8.18 B | 88.8% |
| 2022 | $4.33 B | 12.72% |
| 2021 | $3.84 B | 161.54% |
| 2020 | $1.47 B | 134.27% |
| 2019 | $0.62 B | 81.55% |
| 2018 | $0.34 B | -21.25% |
| 2017 | $0.43 B | -11.01% |
| 2016 | $0.49 B | 19.19% |
| 2015 | $0.41 B | 33.7% |
| 2014 | $0.30 B | 55.27% |
| 2013 | $0.19 B | 112.11% |
| 2012 | $94.02 M | 35.5% |
| 2011 | $69.38 M | -50.38% |
| 2010 | $0.13 B | -21.58% |
| 2009 | $0.17 B | 25.28% |
| 2008 | $0.14 B | -38.94% |
| 2007 | $0.23 B | -28% |
| 2006 | $0.32 B | 84.41% |
| 2005 | $0.17 B | -36.2% |
| 2004 | $0.27 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Cytokinetics was reported to be:
$6.24 Billion
$6.24 Billion
$6.24 Billion
$6.24 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $167.61 B | 2,585.37% | 🇺🇸 USA |
 Trevena TRVN | $7.41 M | -99.88% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.54 B | -75.23% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.99% | 🇺🇸 USA |
 Array Technologies ARRY | $1.66 B | -73.35% | 🇺🇸 USA |